spacer
home > pmps > winter 2019 > perfect packaging
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Perfect Packaging

Far too frequently, life sciences brands have to withdraw products from the market at great cost and risk to their reputation. This is usually because errors have slipped through, which could impact patient safety. Why is this still happening, and what is needed to ensure companies get high quality, compliant products onto the market promptly and efficiently? This article explores the challenges and charts a way forward.

In this age of automation, it seems astounding that some fundamental tasks, such as packaging and labelling quality checks, are still handled manually, at least to some degree. This is the case, even among some of the biggest pharmaceutical brands, despite the high regulatory standards designed to protect patients, the reputational risks, and steep costs if errors slip through the net.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Marc Chaillou is Regional Sales Director at Schlafender Hase, a company that provides intelligent proofreading software, managing key accounts and collaborating with sales partners in export markets. Before joining the company seven years ago, he worked in business development roles at technology market analysts Gartner and Datamonitor. Marc speaks four languages fluently: French, English, Spanish, and German.
spacer
Marc Chaillou
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’

CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says favourable conditions in the UAE are resulting in a boom of pharmaceutical manufacturing throughout the region. Government incentive schemes to increase domestic production, coupled with a brand friendly environment and rising healthcare needs is fuelling surging demand – with many new companies and plants launching in the last two years alone.
More info >>

White Papers

R&D to Product: How to Reduce Costly Scale-Up Problems

Natoli Engineering Company, Inc.

When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement